Medicis Pharmaceutical Corp. (MRX) Tops Q1 EPS by 18c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $72.51 +4.20%
Financial Fact:
Operating income (loss): 15.78M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Operating income (loss): 15.78M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NYSE: MRX) reported Q1 EPS of $0.60, $0.18 better than the analyst estimate of $0.42. Revenue for the quarter came in at $201.7 million versus the consensus estimate of $185.15 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
- Vireo Growth completes acquisition of C21 Investments
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
